[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correspondence
July 2010

Value of the Detection of Circulating Antibodies Against BP Antigens in Unaffected Subjects—Reply

Author Affiliations

Author Affiliation: Departments of Medicine (Dermatology) and Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee.

Arch Dermatol. 2010;146(7):801-802. doi:10.1001/archdermatol.2010.138

In reply

When used as a diagnostic marker of bullous BP, the detection by ELISA of autoantibodies against either of the 2 BP antigens (BPAG1 or BPAG2) in the absence of clinical evidence of disease must be considered to be a false-positive finding, by definition, even though these autoantibodies can be shown to bind to purified antigen. However, such a finding may prove clinically relevant, as opposed to representing an epiphenomenon, if the presence of either autoantibody can be shown to predict who might later develop BP.

First Page Preview View Large
First page PDF preview
First page PDF preview
×